MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Toews, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Toews, M. L.

0026-895X/97/020306-08$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:306-313 (1997).

A Mutation in the Hamster alpha 1B-Adrenergic Receptor that Differentiates Two Steps in the Pathway of Receptor Internalization

Jiefa Wang, Jialin Zheng, Jodi L. Anderson, and Myron L. Toews

Department of Pharmacology, University of Nebraska Medical Center, Omaha, Nebraska 68198-6260

An NP(X)nY motif is highly conserved among G protein-coupled receptors and is similar to an NPXY motif involved in receptor-mediated endocytosis for several non-G protein-coupled receptors. We investigated the role of this motif in alpha 1B-adrenergic receptor function and regulation. Y348A alpha 1B-adrenergic receptors in which this sequence was mutated from NPIIY to NPIIA were prepared by site-directed mutagenesis and transfected into Chinese hamster ovary cells. Binding of the antagonist prazosin to Y348A receptors was similar to that of wild-type receptors, but affinity of the Y348A receptors for the agonist epinephrine was increased by ~10-fold. Despite this increase in agonist binding affinity, the Y348A mutation completely uncoupled the receptors from stimulation of phosphoinositide hydrolysis and mobilization of intracellular Ca2+. Exposure of cells expressing Y348A receptors to the agonist epinephrine resulted in receptor "sequestration," defined as a loss of cell surface receptors accessible to radioligand in binding assays with intact cells on ice, similar to that for the wild-type receptor. In contrast, Y348A receptors did not undergo "endocytosis" into the light vesicle fraction in sucrose density gradient centrifugation assays, as did the wild-type receptor. These results (i) indicate an important role for Tyr348 in coupling the alpha 1B-adrenergic receptor to G protein and subsequent effector activation, (ii) provide further evidence that alpha 1B-adrenergic receptor internalization can be separated into a sequestration step and an endocytosis step, (iii) indicate that effector activation and second messenger formation are not required for the sequestration of these receptors but may be involved in endocytosis, and (iv) provide a useful new tool for further investigation of the nature of the subcellular compartments and the molecular modifications involved in the multiple steps involved in internalization of G protein-coupled receptors.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Kalatskaya, S. Schussler, A. Blaukat, W. Muller-Esterl, M. Jochum, D. Proud, and A. Faussner
Mutation of Tyrosine in the Conserved NPXXY Sequence Leads to Constitutive Phosphorylation and Internalization, but Not Signaling, of the Human B2 Bradykinin Receptor
J. Biol. Chem., July 23, 2004; 279(30): 31268 - 31276.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Hague, Z. Chen, A. S. Pupo, N. A. Schulte, M. L. Toews, and K. P. Minneman
The N Terminus of the Human {alpha}1D-Adrenergic Receptor Prevents Cell Surface Expression
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 388 - 397.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. C. Prinster, N. A. Schulte, M. R. Collins, and M. L. Toews
Up-Regulation of {alpha}1B-Adrenergic Receptors with Defects in G Protein Coupling: Ligand-Induced Protection from Receptor Instability
Mol. Pharmacol., November 1, 2003; 64(5): 1126 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
J. Liu and J. I. Shapiro
Endocytosis and Signal Transduction: Basic Science Update
Biol Res Nurs, October 1, 2003; 5(2): 117 - 128.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Lee, A. Robeva, Z. Chen, and K. P. Minneman
Mutational Uncoupling of {alpha}1A-Adrenergic Receptors from G Proteins Also Uncouples Mitogenic and Transcriptional Responses in PC12 Cells
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 471 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Prioleau, I. Visiers, B. J. Ebersole, H. Weinstein, and S. C. Sealfon
Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor. IDENTIFICATION OF A NOVEL "LOCKED-ON" PHENOTYPE AND DOUBLE REVERTANT MUTATIONS
J. Biol. Chem., September 20, 2002; 277(39): 36577 - 36584.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Chalothorn, D. F. McCune, S. E. Edelmann, M. L. Garcia-Cazarin, G. Tsujimoto, and M. T. Piascik
Differences in the Cellular Localization and Agonist-Mediated Internalization Properties of the alpha 1-Adrenoceptor Subtypes
Mol. Pharmacol., May 1, 2002; 61(5): 1008 - 1016.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Wang, L. Wang, J. L. Anderson, N. A. Schulte, and M. L. Toews
Regulatory Properties of alpha 1B-Adrenergic Receptors Defective in Coupling to Phosphoinositide Hydrolysis
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 134 - 141.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Wang, L. Wang, J. Zheng, J. L. Anderson, and M. L. Toews
Identification of Distinct Carboxyl-Terminal Domains Mediating Internalization and Down-Regulation of the Hamster alpha 1B- Adrenergic Receptor
Mol. Pharmacol., April 1, 2000; 57(4): 687 - 694.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Z.-L. Lu and E. C. Hulme
A Network of Conserved Intramolecular Contacts Defines the Off-state of the Transmembrane Switch Mechanism in a Seven-transmembrane Receptor
J. Biol. Chem., February 25, 2000; 275(8): 5682 - 5686.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
L. Oliveira, A.C.M. Paiva, and G. Vriend
A low resolution model for the interaction of G proteins with G protein-coupled receptors
Protein Eng. Des. Sel., December 1, 1999; 12(12): 1087 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Adams, T. S. Obertone, X. Wang, and T. J. Murphy
Relationship between Internalization and mRNA Decay in Down-Regulation of Recombinant Type 1 Angiotensin II Receptor (AT1) Expression in Smooth Muscle Cells
Mol. Pharmacol., June 1, 1999; 55(6): 1028 - 1036.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Z.-L. Lu, J. W. Saldanha, and E. C. Hulme
Transmembrane Domains 4 and 7 of the M1 Muscarinic Acetylcholine Receptor Are Critical for Ligand Binding and the Receptor Activation Switch
J. Biol. Chem., August 31, 2001; 276(36): 34098 - 34104.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics